Media-OutReach Newswire Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized Phase 2b/3 clinical trial
Media-OutReach Newswire This World Heart Day, Amgen Is Releasing Results of a Global Survey Of 3,200 Heart Attack Survivors Conducted Across 13 Countries